FDA review: Statins don't raise risk of Lou Gehrig's disease

09/29/2008 | Reuters

An FDA analysis of 41 long-term controlled clinical studies did not find increased incidence of Lou Gehrig's disease -- amyotrophic lateral sclerosis -- in patients who took cholesterol-lowering statins compared with those who got placebo. An FDA official said the result was "reassuring" but recommended continued research into the safety of such drugs for ALS patients.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care